Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Shareholders' Equity Unaudited

v3.10.0.1
Condensed Statements of Shareholders' Equity Unaudited - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Sep. 30, 2017 13,812,821      
Balance at Sep. 30, 2017 $ 138,128 $ 55,406,888 $ 8,980,104 $ 64,525,120
Stock-based compensation expense   483,287   483,287
Repurchase of common stock (in shares) (900)      
Repurchase of common stock $ (9) (10,841)   (10,850)
Restricted stock issuance, net (in shares) (4,376)      
Restricted stock issuance, net $ (44) 44    
Issuance of common stock under employee stock purchase plan (in shares) 14,242      
Issuance of common stock under employee stock purchase plan $ 142 148,117   148,259
Exercise of stock options, net of shares exchanged for payment (in shares) 3,075      
Exercise of stock options, net of shares exchanged for payment $ 32 3,217   3,249
Tax withholding related to vesting of restricted stock grants (in shares) (671)      
Tax withholding related to vesting of restricted stock grants $ (7) (9,255)   (9,262)
Net income     943,158 943,158
Balance (in shares) at Dec. 31, 2017 13,824,191      
Balance at Dec. 31, 2017 $ 138,242 56,021,457 9,923,262 66,082,961
Balance (in shares) at Sep. 30, 2018 13,646,553      
Balance at Sep. 30, 2018 $ 136,466 55,483,759 13,254,651 68,874,876
Stock-based compensation expense   538,524   538,524
Restricted stock issuance, net (in shares) (3,838)      
Restricted stock issuance, net $ (38) 38    
Issuance of common stock under employee stock purchase plan (in shares) 17,312      
Issuance of common stock under employee stock purchase plan $ 173 145,767   145,940
Exercise of stock options, net of shares exchanged for payment (in shares) 2,974      
Exercise of stock options, net of shares exchanged for payment $ 29 (12)   17
Tax withholding related to vesting of restricted stock grants (in shares) (545)      
Tax withholding related to vesting of restricted stock grants $ (5) (6,671)   (6,676)
Net income     1,009,960 1,009,960
Balance (in shares) at Dec. 31, 2018 13,662,456      
Balance at Dec. 31, 2018 $ 136,625 $ 56,161,405 $ 14,264,611 $ 70,562,641